Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

Wednesday’s trading has closed, but ALXN is being traded in the after-hours session. After-Hours quote »
177.78
Data as of 3:59pm ET
 -2.58 / -1.43%
Today’s Change
128.89
Today|||52-Week Range
203.30
-3.92%
Year-to-Date
Amgen Beats on Q4 Earnings & Revenues, Maintains Outlook - Analyst Blog
10:39am / Zacks.com
State of the Union Address Investing Idea: Precision Medicine
Jan 21 / MotleyFool.com
Gilead Includes Pan-Genotypic Agent in HCV Licensing Deals - Analyst Blog
Jan 27 / Zacks.com
Affymetrix Hits 52-Week High on Strong Top-Line Growth - Analyst Blog
Jan 21 / Zacks.com
The Medicines Co. Gets CHMP Recommendation for 3 Drugs - Analyst Blog
Jan 27 / Zacks.com
Applied Genetic Technologies (AGTC) in Focus: Stock Rises 6.6% - Tale of the Tape
Jan 21 / Zacks.com
Will Alexion's (ALXN) Soliris Drive Q4 Earnings Beat? - Analyst Blog
Jan 27 / Zacks.com
AMAG Pharmaceuticals (AMAG) in Focus: Stock Rises 5.8% - Tale of the Tape
Jan 21 / Zacks.com
5 Big Biotech Earnings Releases To Watch This Week
Jan 26 / Benzinga
Supernus Downgraded as Lead Drugs Face Patent Challenges - Analyst Blog
Jan 20 / Zacks.com
Minerva Neurosciences Gains on Positive Data on MIN-202 - Analyst Blog
Jan 23 / Zacks.com
Celgene Up as Otezla Gains EU Approval for Two Indications - Analyst Blog
Jan 19 / Zacks.com
Sanofi's Cerdelga Cleared in the EU for Gaucher Disease - Analyst Blog
Jan 23 / Zacks.com
Alkermes plc (ALKS) in Focus: Stock Moves 6.6% Higher - Tale of the Tape
Jan 19 / Zacks.com
BioMarin to Raise Funds to Finance Prosensa Acquisition - Analyst Blog
Jan 22 / Zacks.com
BioDelivery Sciences International (BDSI) in Focus: Stock Up 5% - Tale of the Tape
Jan 19 / Zacks.com
Illumina Launches MiSeq FGx for Forensic DNA Analysis - Analyst Blog
Jan 22 / Zacks.com
Illumina Unveils 3 NGS Systems, Modifies Business Strategy - Analyst Blog
Jan 16 / Zacks.com
Endo Prices $1.2B Senior Notes Offering for Auxilium Deal - Analyst Blog
Jan 22 / Zacks.com
OncoMed Starts Expansion Stage Study for Solid Tumor Drug - Analyst Blog
Jan 16 / Zacks.com
Keryx to Raise $110 Million Through Issuance of Shares - Analyst Blog
Jan 22 / Zacks.com
Sarepta Starts Dosing in Duchenne Muscular Dystrophy Study - Analyst Blog
Jan 15 / Zacks.com
Arena Pharmaceuticals to Raise Fund Via Share Issuance - Analyst Blog
Jan 22 / Zacks.com
Illumina Declares Impressive Q4, 2014 Preliminary Results - Analyst Blog
Jan 15 / Zacks.com
Merrimack Reveals Additional Data from Oncology Candidate - Analyst Blog
Jan 22 / Zacks.com
Regado Biosciences to Merge with Tobira Therapeutics - Analyst Blog
Jan 15 / Zacks.com
Celgene to Use Zymeworks' Azymetric Platform for New Drugs - Analyst Blog
Jan 22 / Zacks.com
Qiagen Up on CE-IVD Mark for New Liquid Biopsy Test Kit - Analyst Blog
Jan 15 / Zacks.com
Kite Pharma (KITE) in Focus: Stock Tumbles 9.2% - Tale of the Tape
Jan 22 / Zacks.com
BioMarin Gains on Vimizim 2014 View, Batten Disease Data - Analyst Blog
Jan 14 / Zacks.com
Keryx Biopharmaceuticals (KERX) in Focus: Stock Falls by 6.8% - Tale of the Tape
Jan 22 / Zacks.com
Qiagen Up on Enzymatics' Unit Buy, ArcherDX Partnership Deal - Analyst Blog
Jan 14 / Zacks.com
Alnylam to Raise $450 Million Through Issuance of Shares - Analyst Blog
Jan 21 / Zacks.com
 

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.